AKTSAktis Oncology, Inc.
$15.71
$15.71
$15.0752 weeks$32.34
What is the market doing?
Mixed
2 neutral, 1 without dataNo clear lean: insiders net selling (often routine) and heavily shorted.
Insider conviction−$259K (90 days to Oct 22, 2026)SEC EDGAR · Oct 22, 2026
Insiders were net sellers over the 90 days ending Oct 22, 2026; selling is often routine (taxes, diversification).
Short interest9.7% of sharesFINRA · Sep 30, 2026
Heavily shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AKTS is trading
- Below its 52-week high
- 51%
Below its 52-week high
Details›
- Last close2026-10-23
- $15.71
- 1 monthS&P 500 −0.94%
- −20%
- 52-week high
- $32.34
- 52-week low
- $15.06
- Annualised volatility
- 68%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $3.0M
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry